Loading provider…
Loading provider…
Internal Medicine Physician in Omaha, NE
NPI: 1245354737Primary Employer
Binney Medical Associates
brighamandwomens.org
HQ Phone
Get M.D. Nikhil's Phone Numberphone_androidMobile
Get M.D. Nikhil's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
Genomic Characterization of de novo Metastatic Breast Cancer.
Authors: Esha Jain, Bruce Johnson, Liam Spurr, Ian Krop
Journal: Clin Cancer Res
Publication Date: 2020-12-08
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.
Authors: James Cleary, Geoffrey Shapiro, Mary-Ellen Taplin, Toni Choueiri
Publication Date: 2014-03-15
Response and acquired resistance to everolimus in anaplastic thyroid cancer.
Authors: Daniel Ruan, Jochen Lorch, David Kwiatkowski
Publication Date: 2014-10-09
Lead Sponsor: Dana-Farber Cancer Institute
Collaborators: AstraZeneca, Cyclacel Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Olaparib, DRUG: Sapacitabine
Lead Sponsor: Dana-Farber Cancer Institute
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Trastuzumab, DRUG: Tucatinib, DRUG: Aromatase Inhibitor
Lead Sponsor: Dana-Farber Cancer Institute
Collaborators: Mayo Clinic
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cyclophosphamide, DRUG: Paclitaxel